| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Georgetown Brain Tumor Center and Department of Neurosurgery, Georgetown University Medical Center, Washington, DC 20007
We have demonstrated that attenuated mutants of herpes simplex virus (HSV) have therapeutic potential for malignant brain tumors. In this report, we tested a ribonucleotide reductase-deficient (RR-) HSV mutant as an experimental treatment for malignant brain tumors. The HSV-RR- mutant hrR3, containing an Escherichia coli lacZ gene insertion in the ICP6 gene that encodes the large subunit of RR, was used in this study. We examined the cytopathic effect of hrR3 (0.1 plaque-forming unit/cell) on the U-87MG human glioblastoma cell line in vitro. Only 0.2% of U-87 cells were alive 67 h postinfection. Drug sensitivity assays demonstrated that hrR3 is hypersensitive to the antiherpetic agent ganciclovir. For in vivo studies, 10 animals harboring U-87MG tumors were randomly divided and treated intraneoplastically with either 5 x 106 plaque-forming units of hrR3 or medium alone. The viral treatment group showed significant inhibition of tumor growth (P < 0.01; one-sided Wilcoxon rank test). Expression of the lacZ gene in hrR3, visualized by 5-bromo-4-Chrolo-3-indolyl-ß-D-galactopyranoside histochemistry, could be detected in treated tumors. The therapeutic potential of this HSV-RR- mutant for malignant gliomas is discussed.
1 This study was supported in part by NIH Grants CA60176 and NS323677.
2 To whom requests for reprints should be addressed, at Department of Neurosurgery, Georgetown University Medical Center, 3800 Reservoir Road, N. W., Washington, DC 20007.
Received 4/28/94. Accepted 6/ 9/94.
This article has been cited by other articles:
|
|
 |
|
  X. Lun, D. L. Senger, T. Alain, A. Oprea, K. Parato, D. Stojdl, B. Lichty, A. Power, R. N. Johnston, M. Hamilton, et al. Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSV{Delta}M51) on Multifocal and Invasive Gliomas. J Natl Cancer Inst, November 1, 2006; 98(21): 1546 - 1557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kuroda, S. D. Rabkin, and R. L. Martuza Effective Treatment of Tumors with Strong {beta}-Catenin/T-Cell Factor Activity by Transcriptionally Targeted Oncolytic Herpes Simplex Virus Vector. Cancer Res., October 15, 2006; 66(20): 10127 - 10135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Shah, K. H. Price, J. N. Parker, S. L. Samuel, S. Meleth, K. A. Cassady, G. Yancey Gillespie, R. J. Whitley, and J. M. Markert Serial Passage through Human Glioma Xenografts Selects for a {Delta}{gamma}134.5 Herpes Simplex Virus Type 1 Mutant That Exhibits Decreased Neurotoxicity and Prolongs Survival of Mice with Experimental Brain Tumors. J. Virol., August 1, 2006; 80(15): 7308 - 7315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Fu, L. Tao, M. Li, W. E. Fisher, and X. Zhang Effective treatment of pancreatic cancer xenografts with a conditionally replicating virus derived from type 2 herpes simplex virus. Clin. Cancer Res., May 15, 2006; 12(10): 3152 - 3157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zhou and B. Roizman Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13{alpha}2 receptor PNAS, April 4, 2006; 103(14): 5508 - 5513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Curiel Next Generation CRAds for Virotherapy of Cancer Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 141 - 144. [Full Text] [PDF]
|
|
|
|
|
|
S. F. Stanziale, H. Petrowsky, P. S. Adusumilli, L. Ben-Porat, M. Gonen, and Y. Fong Infection with Oncolytic Herpes Simplex Virus-1 Induces Apoptosis in Neighboring Human Cancer Cells: A Potential Target to Increase Anticancer Activity Clin. Cancer Res., May 1, 2004; 10(9): 3225 - 3232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cinatl Jr., J. Cinatl, M. Michaelis, H. Kabickova, R. Kotchetkov, J.-U. Vogel, H. W. Doerr, T. Klingebiel, and P. H. Driever Potent Oncolytic Activity of Multimutated Herpes Simplex Virus G207 in Combination with Vincristine against Human Rhabdomyosarcoma Cancer Res., April 1, 2003; 63(7): 1508 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Fu and X. Zhang Potent Systemic Antitumor Activity from an Oncolytic Herpes Simplex Virus of Syncytial Phenotype Cancer Res., April 1, 2002; 62(8): 2306 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Mullen and K. K. Tanabe Viral Oncolysis Oncologist, April 1, 2002; 7(2): 106 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. A. Ring Cytolytic viruses as potential anti-cancer agents J. Gen. Virol., March 1, 2002; 83(3): 491 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakamura, J. T. Mullen, S. Chandrasekhar, T. M. Pawlik, S. S. Yoon, and K. K. Tanabe Multimodality Therapy with a Replication-conditional Herpes Simplex Virus 1 Mutant that Expresses Yeast Cytosine Deaminase for Intratumoral Conversion of 5-Fluorocytosine to 5-Fluorouracil Cancer Res., July 1, 2001; 61(14): 5447 - 5452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Mohr, D. Sternberg, S. Ward, D. Leib, M. Mulvey, and Y. Gluzman A Herpes Simplex Virus Type 1 {gamma}34.5 Second-Site Suppressor Mutant That Exhibits Enhanced Growth in Cultured Glioblastoma Cells Is Severely Attenuated in Animals J. Virol., June 1, 2001; 75(11): 5189 - 5196. [Abstract] [Full Text]
|
|
|
|
|
|
A. Jacobs, J. G. Tjuvajev, M. Dubrovin, T. Akhurst, J. Balatoni, B. Beattie, R. Joshi, R. Finn, S. M. Larson, U. Herrlinger, et al. Positron Emission Tomography-based Imaging of Transgene Expression Mediated by Replication-conditional, Oncolytic Herpes Simplex Virus Type 1 Mutant Vectors in Vivo Cancer Res., April 1, 2001; 61(7): 2983 - 2995. [Abstract] [Full Text]
|
|
|
|
|
|
C. G. Miller and N. W. Fraser Role of the Immune Response during Neuro-attenuated Herpes Simplex Virus-mediated Tumor Destruction in a Murine Intracranial Melanoma Model Cancer Res., October 1, 2000; 60(20): 5714 - 5722. [Abstract] [Full Text]
|
|
|
|
|
|
G. Coukos, A. Makrigiannakis, E. H. Kang, S. C. Rubin, S. M. Albelda, and K. L. Molnar-Kimber Oncolytic Herpes Simplex Virus-1 Lacking ICP34.5 Induces p53-independent Death and Is Efficacious against Chemotherapy-resistant Ovarian Cancer Clin. Cancer Res., August 1, 2000; 6(8): 3342 - 3353. [Abstract] [Full Text]
|
|
|
|
|
|
P. Sundaresan, W. D. Hunter, R. L. Martuza, and S. D. Rabkin Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation in Mice J. Virol., April 15, 2000; 74(8): 3832 - 3841. [Abstract] [Full Text]
|
|
|
|
|
|
D. B. Anderson, S. Laquerre, W. F. Goins, J. B. Cohen, and J. C. Glorioso Pseudotyping of Glycoprotein D-Deficient Herpes Simplex Virus Type 1 with Vesicular Stomatitis Virus Glycoprotein G Enables Mutant Virus Attachment and Entry J. Virol., March 1, 2000; 74(5): 2481 - 2487. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. S. YOON, H. NAKAMURA, N. M. CARROLL, B. P. BODE, E. A. CHIOCCA, and K. K. TANABE An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma FASEB J, February 1, 2000; 14(2): 301 - 311. [Abstract] [Full Text]
|
|
|
|
 |
|
 S.-I. Miyatake, H. Yukawa, H. Toda, N. Matsuoka, R. Takahashi, N. Hashimoto, and C. D. Kontos Inhibition of Rat Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Recombinant Replication-Competent Herpes Simplex Virus • Editorial Comment Stroke, November 1, 1999; 30 (11): 2431 - 2439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Y. Chung, Y. Saeki, and E. A. Chiocca B-myb Promoter Retargeting of Herpes Simplex Virus gamma 34.5 Gene-Mediated Virulence toward Tumor and Cycling Cells J. Virol., September 1, 1999; 73(9): 7556 - 7564. [Abstract] [Full Text]
|
|
|
|
|
|
W. D. Hunter, R. L. Martuza, F. Feigenbaum, T. Todo, T. Mineta, T. Yazaki, M. Toda, J. T. Newsome, R. C. Platenberg, H. J. Manz, et al. Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates J. Virol., August 1, 1999; 73(8): 6319 - 6326. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Bradley, Y. Kataoka, S. Advani, S. M. Chung, R. B. Arani, G. Y. Gillespie, R. J. Whitley, J. M. Markert, B. Roizman, and R. R. Weichselbaum Ionizing Radiation Improves Survival in Mice Bearing Intracranial High-Grade Gliomas Injected with Genetically Modified Herpes Simplex Virus Clin. Cancer Res., June 1, 1999; 5(6): 1517 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Coukos, A. Makrigiannakis, E. H. Kang, D. Caparelli, I. Benjamin, L. R. Kaiser, S. C. Rubin, S. M. Albelda, and K. L. Molnar-Kimber Use of Carrier Cells to Deliver a Replication-selective Herpes Simplex Virus-1 Mutant for the Intraperitoneal Therapy of Epithelial Ovarian Cancer Clin. Cancer Res., June 1, 1999; 5(6): 1523 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Advani, S.-M. Chung, S. Y. Yan, G. Y. Gillespie, J. M. Markert, R. J. Whitley, B. Roizman, and R. R. Weichselbaum Replication-competent, Nonneuroinvasive Genetically Engineered Herpes Virus Is Highly Effective in the Treatment of Therapy-resistant Experimental Human Tumors Cancer Res., May 1, 1999; 59(9): 2055 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rancourt, A. Piche, J. Gomez-Navarro, M. Wang, R. D. Alvarez, G. P. Siegal, G. M. Fuller, S. A. Jones, and D. T. Curiel Interleukin-6 Modulated Conditionally Replicative Adenovirus as an Antitumor/Cytotoxic Agent for Cancer Therapy Clin. Cancer Res., January 1, 1999; 5(1): 43 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dilloo, D. Rill, C. Entwistle, M. Boursnell, W. Zhong, W. Holden, M. Holladay, S. Inglis, and M. Brenner A Novel Herpes Vector for the High-Efficiency Transduction of Normal and Malignant Human Hematopoietic Cells Blood, January 1, 1997; 89(1): 119 - 127. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
